Recurring services and consumables, centralized high-throughput labs, automation, payer connectivity and outsourced testing support scale, efficiency and sustainable returns.Dublin, Oct. 16, 2026 ...
The global cancer diagnostics market is valued at USD 29.3 billion in 2026 and is projected to reach USD 41.5 billion by 2031, growing at a CAGR of 7.2% over the forecast period (2026–2031), according ...
A new case report describes how chromosomal microarray and trio whole-exome sequencing revealed a 10.42 Mb homozygous segment ...
I was told the amniocentesis results came in two days earlier than expected. I received a phone call, so I headed to the ...
A 9-month-old male was referred due to developmental concerns, including being unable to sit unsupported and persistent head ...
Landmark Nationwide Trial Shows Genome Sequencing Beats Standard Testing for Developmental Disorders
A nationwide Belgian randomized trial of 567 patients found that genome sequencing diagnosed 39.8 percent of developmental disorder cases, significantly outperforming the standard combination of exome ...
GeneDx ha annunciato che presenterà Easy Order in occasione della Conferenza nazionale e dell'Esposizione 2026 dell'American Academy of Pediatrics , in programma dal 2 al 6 ottobre a San Diego.
GeneDx announced it will introduce Easy Order at the 2026 American Academy of Pediatrics (AAP) National Conference & Exhibition, October 2-6 in San Diego. The new streamlined experience makes it ...
Bionano Laboratories has validated its OGM-Dx HemeOne diagnostic test for hematologic malignancy analysis. The test is expected to be eligible for coverage under the proposed LCD once the policy is ...
The chromosomal array is a laboratory test that can be used to detect genetic abnormalities in an individual. It is a powerful tool that can help diagnose and monitor genetic conditions, both ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results